• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生存数据分析中的竞争风险。

Competing risks in survival data analysis.

机构信息

OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden - Rossendorf, Dresden, Germany; Helmholtz-Zentrum Dresden - Rossendorf, Institute of Radiooncology - OncoRay, Dresden, Germany.

OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden - Rossendorf, Dresden, Germany; German Cancer Consortium (DKTK), Partner Site Dresden, and German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.

出版信息

Radiother Oncol. 2019 Jan;130:185-189. doi: 10.1016/j.radonc.2018.09.007. Epub 2018 Oct 9.

DOI:10.1016/j.radonc.2018.09.007
PMID:30314718
Abstract

Clinical trials and retrospective studies in the field of radiation oncology often consider time-to-event data as their primary endpoint. Such studies are susceptible to competing risks, i.e. competing events may preclude the occurrence of the event of interest or modify the chance that the primary endpoint occurs. Competing risks are frequently neglected and the event of interest is analysed with standard statistical methods. Here, we would like to create awareness of the problem and demonstrate different methods for survival data analysis in the presence of competing risks.

摘要

在放射肿瘤学领域的临床试验和回顾性研究中,通常将生存时间数据作为主要终点。此类研究易受到竞争风险的影响,即竞争事件可能会阻止感兴趣事件的发生,或改变主要终点发生的机会。竞争风险经常被忽视,并且使用标准统计方法分析感兴趣事件。在这里,我们希望引起人们对该问题的认识,并展示在存在竞争风险的情况下进行生存数据分析的不同方法。

相似文献

1
Competing risks in survival data analysis. 生存数据分析中的竞争风险。
Radiother Oncol. 2019 Jan;130:185-189. doi: 10.1016/j.radonc.2018.09.007. Epub 2018 Oct 9.
2
High neutrophil-to-lymphocyte ratio predicts poor prognosis in patients with squamous cell carcinoma of the head and neck treated with definitive chemoradiotherapy.高中性粒细胞与淋巴细胞比值预示着接受根治性放化疗的头颈部鳞状细胞癌患者预后不良。
Asia Pac J Clin Oncol. 2018 Oct;14(5):e442-e447. doi: 10.1111/ajco.12846. Epub 2018 Jan 17.
3
Single-Arm Phase 2 Trial of Elective Nodal Dose Reduction for Patients With Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck.局部晚期头颈部鳞状细胞癌选择性淋巴结剂量减少的单臂 2 期试验。
Int J Radiat Oncol Biol Phys. 2018 Apr 1;100(5):1210-1216. doi: 10.1016/j.ijrobp.2017.12.277. Epub 2017 Dec 28.
4
Survival benefit of post-operative chemotherapy for intermediate-risk advanced stage head and neck cancer differs with patient age.术后化疗对中危期头颈部癌症的生存获益因患者年龄而异。
Oral Oncol. 2018 Sep;84:71-75. doi: 10.1016/j.oraloncology.2018.07.012. Epub 2018 Jul 21.
5
Definitive radiation with concurrent cetuximab vs. radiation with or without concurrent cytotoxic chemotherapy in older patients with squamous cell carcinoma of the head and neck: Analysis of the SEER-medicare linked database.头颈部鳞状细胞癌老年患者中,同期西妥昔单抗放疗与单纯放疗或同期细胞毒化疗的比较:SEER-医疗保险数据库分析。
Oral Oncol. 2018 Nov;86:132-140. doi: 10.1016/j.oraloncology.2018.09.023. Epub 2018 Sep 21.
6
Primary Cancer vs Competing Causes of Death in Survivors of Head and Neck Cancer.头颈部癌症幸存者的原发性癌症与竞争死亡原因。
JAMA Oncol. 2018 Feb 1;4(2):257-259. doi: 10.1001/jamaoncol.2017.4478.
7
Prevalence of Comorbidities among Older Head and Neck Cancer Survivors in the United States.美国老年头颈部癌症幸存者合并症的患病率。
Otolaryngol Head Neck Surg. 2019 Jan;160(1):85-92. doi: 10.1177/0194599818796163. Epub 2018 Sep 25.
8
Patterns of care and outcomes of adjuvant therapy for high-risk head and neck cancer after surgery.手术后高危头颈部癌症辅助治疗的护理模式和结果。
Head Neck. 2018 Jun;40(6):1254-1262. doi: 10.1002/hed.25103. Epub 2018 Feb 16.
9
Postoperative chemoradiotherapy in patients with head and neck cancer aged 70 or older with positive margins or extranodal extension and the influence of nodal classification.70 岁及以上头颈部癌症患者伴有切缘阳性或结外侵犯且伴有淋巴结分类影响的术后放化疗。
Head Neck. 2018 Jun;40(6):1228-1236. doi: 10.1002/hed.25100. Epub 2018 Feb 8.
10
Racial disparity in oncologic and quality-of-life outcomes in patients with locally advanced head and neck squamous cell carcinomas enrolled in a randomized phase 2 trial.在一项随机的 2 期临床试验中,局部晚期头颈部鳞状细胞癌患者的肿瘤学和生活质量结局存在种族差异。
Cancer. 2018 Jul 1;124(13):2841-2849. doi: 10.1002/cncr.31407. Epub 2018 Apr 18.

引用本文的文献

1
Uncertainties in outcome modelling in radiation oncology.放射肿瘤学中结果建模的不确定性。
Phys Imaging Radiat Oncol. 2025 May 7;34:100774. doi: 10.1016/j.phro.2025.100774. eCollection 2025 Apr.
2
Association between exposure to urinary metal and all-cause and cardiovascular mortality in US adults.美国成年人接触尿金属与全因死亡率和心血管死亡率之间的关联。
PLoS One. 2024 Dec 27;19(12):e0316045. doi: 10.1371/journal.pone.0316045. eCollection 2024.
3
Understanding factors limiting hematopoietic cell transplantation for acute myeloid leukemia patients in Mexico: a comprehensive analysis.
了解限制墨西哥急性髓细胞白血病患者进行造血细胞移植的因素:综合分析。
Ann Hematol. 2024 Oct;103(10):4089-4097. doi: 10.1007/s00277-024-05956-w. Epub 2024 Aug 23.
4
Estimation of treatment effect in presence of noncompliance and competing risks: a simulation study.存在不依从和竞争风险时的治疗效果估计:一项模拟研究。
Sci Rep. 2023 Aug 18;13(1):13477. doi: 10.1038/s41598-023-40538-2.
5
Comparison of Clinical Outcomes, Pathologic Characteristics, and Immune-Related Features of Postradiation vs Sporadic Oral Cavity Squamous Cell Carcinoma.放疗后与散发性口腔鳞状细胞癌的临床结局、病理特征和免疫相关特征比较。
JAMA Netw Open. 2023 Jul 3;6(7):e2323890. doi: 10.1001/jamanetworkopen.2023.23890.
6
Long-term outcomes of duckbill-type anti-reflux metal stents versus conventional covered metal stents in reinterventions after covered biliary metal stent dysfunction in unresectable pancreatic cancer.不可切除胰腺癌覆膜胆道金属支架功能障碍后再次干预时,鸭嘴型抗反流金属支架与传统覆膜金属支架的长期疗效比较。
Surg Endosc. 2023 May;37(5):3498-3506. doi: 10.1007/s00464-022-09836-0. Epub 2022 Dec 29.
7
The Risk of Heart Disease-Related Death Among Anaplastic Astrocytoma Patients After Chemotherapy: A SEER Population-Based Analysis.间变性星形细胞瘤患者化疗后心脏病相关死亡风险:一项基于监测、流行病学和最终结果(SEER)数据库的人群分析
Front Oncol. 2022 Jun 20;12:870843. doi: 10.3389/fonc.2022.870843. eCollection 2022.
8
Competing Risk Analysis of Outcomes of Unresectable Pancreatic Cancer Patients Undergoing Definitive Radiotherapy.不可切除胰腺癌患者接受根治性放疗后结局的竞争风险分析
Front Oncol. 2022 Jan 6;11:730646. doi: 10.3389/fonc.2021.730646. eCollection 2021.
9
Analysis of using high-precision radiotherapy in the treatment of liver metastases regarding toxicity and survival.分析高精度放疗治疗肝转移瘤的毒性和生存情况。
BMC Cancer. 2021 Jul 6;21(1):780. doi: 10.1186/s12885-021-08488-y.
10
Methodological evaluation of bias in observational coronavirus disease 2019 studies on drug effectiveness.观察性新型冠状病毒病 2019 药物疗效研究中偏倚的方法学评价。
Clin Microbiol Infect. 2021 Jul;27(7):949-957. doi: 10.1016/j.cmi.2021.03.003. Epub 2021 Apr 1.